We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+18.11%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
10 Year Est. Return
AUM
$514M
AUM Growth
+$169M
Cap. Flow
+$103M
Cap. Flow %
19.96%
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.85M
2
ADI icon
Analog Devices
ADI
+$3.37M
3
AMZN icon
Amazon
AMZN
+$3.21M
4
LULU icon
lululemon athletica
LULU
+$2.87M
5
ORCL icon
Oracle
ORCL
+$1.91M

Sector Composition

Rank Sector Weight
1 Technology 34.39%
2 Healthcare 30.05%
3 Consumer Discretionary 17.55%
4 Communication Services 6.11%
5 Consumer Staples 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GOSS icon
451
Gossamer Bio
GOSS
$86.8M
-5,774
Closed -$4.81K
HLVX
452
DELISTED
HilleVax
HLVX
-1,008
Closed -$13.6K
IGMS
453
DELISTED
IGM Biosciences
IGMS
-837
Closed -$6.99K
NBP
454
NovaBridge Biosciences American Depositary Shares
NBP
$216M
-1,789
Closed -$2.36K
IMRX icon
455
Immuneering
IMRX
$328M
-749
Closed -$5.75K
INO icon
456
Inovio Pharmaceuticals
INO
$79.6M
-574
Closed -$2.68K
IPSC icon
457
Century Therapeutics
IPSC
$353M
-1,528
Closed -$3.06K
IVVD icon
458
Invivyd
IVVD
$216M
-2,816
Closed -$4.79K
KOD icon
459
Kodiak Sciences
KOD
$2.72B
-1,349
Closed -$2.43K
KPTI icon
460
Karyopharm Therapeutics
KPTI
$46M
-195
Closed -$3.92K
KZR
461
DELISTED
Kezar Life Sciences
KZR
-186
Closed -$2.21K
LCID icon
462
Lucid Motors
LCID
$2.58B
-847
Closed -$47.3K
MCRB icon
463
Seres Therapeutics
MCRB
$47.4M
-164
Closed -$7.82K
MRSN
464
DELISTED
Mersana Therapeutics
MRSN
-124
Closed -$3.93K
NKTR icon
465
Nektar Therapeutics
NKTR
$2.57B
-325
Closed -$2.91K
NKTX icon
466
Nkarta
NKTX
$171M
-1,265
Closed -$1.76K
OMER icon
467
Omeros
OMER
$992M
-1,619
Closed -$4.73K
OPTN
468
DELISTED
OptiNose
OPTN
-192
Closed -$3.54K
ORCL icon
469
Oracle
ORCL
$442B
-18,000
Closed -$1.91M
PEPG icon
470
PepGen
PEPG
$201M
-615
Closed -$3.12K
PMVP icon
471
PMV Pharmaceuticals
PMVP
$67.2M
-1,251
Closed -$7.68K
PRLD icon
472
Prelude Therapeutics
PRLD
$456M
-1,076
Closed -$3.33K
QSI icon
473
Quantum-Si Incorporated
QSI
$182M
-3,127
Closed -$5.19K
RNAC icon
474
Cartesian Therapeutics
RNAC
$263M
-131
Closed -$4.17K
RPTX
475
DELISTED
Repare Therapeutics
RPTX
-1,079
Closed -$13K

Similar funds

China Universal Asset Management Company's Q4 2023 Portfolio in Review

As of Q4 2023, China Universal Asset Management Company held 503 positions worth $514M, up 49% from $345M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

China Universal Asset Management Company deployed $103M of net new capital in Q4 2023, opening 57 new positions and adding to 239 existing holdings. Its largest new stake was GSK: 54,345 shares worth $2.03M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $4.85M trimmed.

  • China Universal Asset Management Company's largest Q4 2023 buy was GSK: 54,345 shares worth $2.03M.
  • China Universal Asset Management Company added most to Vertex Pharmaceuticals in Q4 2023, an estimated $6.25M increase.
  • China Universal Asset Management Company's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $4.85M.
  • China Universal Asset Management Company fully exited Oracle in Q4 2023, selling an estimated $1.91M.
  • China Universal Asset Management Company's ten largest holdings make up 27% of its $514M portfolio in Q4 2023.
  • China Universal Asset Management Company opened 57 new positions and closed 78 in Q4 2023.
  • China Universal Asset Management Company's portfolio value rose 49% quarter-over-quarter to $514M.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.